THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS
OBJECTIVE:The incidence of bilateral breast cancer has shown the range from 2% to as high 11%. Breast cancer patients should follow up against the other side breast cancer risk.METHODS:Medical records of patients who were treated for breast cancer were reviewed during a 5 years period of March 2000...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2008-01-01
|
| Series: | European Journal of Breast Health |
| Subjects: | |
| Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/the-evaluaton-of-metachronous-breast-cancer-patent/42681
|
| _version_ | 1797917017885376512 |
|---|---|
| author | Öner Menteş Murat Akın Erkan Öztürk Müjdat Balkan Turgut Tufan |
| author_facet | Öner Menteş Murat Akın Erkan Öztürk Müjdat Balkan Turgut Tufan |
| author_sort | Öner Menteş |
| collection | DOAJ |
| description | OBJECTIVE:The incidence of bilateral breast cancer has shown the range from 2% to as high 11%. Breast cancer patients should follow up against the other side breast cancer risk.METHODS:Medical records of patients who were treated for breast cancer were reviewed during a 5 years period of March 2000 to April 2006. Data of patients found to have bilateral breast cancer (BBC) was analyzed focusing on the demographic information, family history, menstrual status, surgical therapy, staging and histopathological characteristics.RESULTS:Of patients 215 treated for breast cancer 19 (8, 8%) revealed metachronous BBC. The median age was 57, 7 (ranges, 36-77) years. For patients with metachronous breast carcinomas, the median interval between the fi rst and second diagnosis was 8 (ranges, 3-15) years. Six patients with metachronous of them (31,5%) were in postmenopousal, and 13 of them (68, 5%) in premenopousal status. One of metachronous patient revealed positive family history. For metachronous patients, 5, 4, 3, 4 and 3 having stages I, IIA, IIB, IIIA, and IV disease, respectively. The most common type of breast cancer recorded was invasive ductal carcinoma.CONCLUSION:The incidence of BBC reported in this series is similar to the published data. Patients should be evaluated the risk of BBC carefully at the time of diagnosis and during follow up. |
| first_indexed | 2024-04-10T13:06:40Z |
| format | Article |
| id | doaj.art-f852d31a4d6f465cbca85d80a872990a |
| institution | Directory Open Access Journal |
| issn | 2587-0831 |
| language | English |
| last_indexed | 2024-04-10T13:06:40Z |
| publishDate | 2008-01-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | European Journal of Breast Health |
| spelling | doaj.art-f852d31a4d6f465cbca85d80a872990a2023-02-15T16:12:57ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312008-01-0141384013049054THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTSÖner Menteş0Murat Akın1Erkan Öztürk2Müjdat Balkan3Turgut Tufan4 Gülhane Askeri Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Meme Endokrin Cerrahisi Birimi, Ankara, Türkiye Gülhane Askeri Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Meme Endokrin Cerrahisi Birimi, Ankara, Türkiye Gülhane Askeri Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Meme Endokrin Cerrahisi Birimi, Ankara, Türkiye Gülhane Askeri Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Meme Endokrin Cerrahisi Birimi, Ankara, Türkiye Gülhane Askeri Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Meme Endokrin Cerrahisi Birimi, Ankara, Türkiye OBJECTIVE:The incidence of bilateral breast cancer has shown the range from 2% to as high 11%. Breast cancer patients should follow up against the other side breast cancer risk.METHODS:Medical records of patients who were treated for breast cancer were reviewed during a 5 years period of March 2000 to April 2006. Data of patients found to have bilateral breast cancer (BBC) was analyzed focusing on the demographic information, family history, menstrual status, surgical therapy, staging and histopathological characteristics.RESULTS:Of patients 215 treated for breast cancer 19 (8, 8%) revealed metachronous BBC. The median age was 57, 7 (ranges, 36-77) years. For patients with metachronous breast carcinomas, the median interval between the fi rst and second diagnosis was 8 (ranges, 3-15) years. Six patients with metachronous of them (31,5%) were in postmenopousal, and 13 of them (68, 5%) in premenopousal status. One of metachronous patient revealed positive family history. For metachronous patients, 5, 4, 3, 4 and 3 having stages I, IIA, IIB, IIIA, and IV disease, respectively. The most common type of breast cancer recorded was invasive ductal carcinoma.CONCLUSION:The incidence of BBC reported in this series is similar to the published data. Patients should be evaluated the risk of BBC carefully at the time of diagnosis and during follow up. http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/the-evaluaton-of-metachronous-breast-cancer-patent/42681 metachronous cancerbilateral breast cancer |
| spellingShingle | Öner Menteş Murat Akın Erkan Öztürk Müjdat Balkan Turgut Tufan THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS European Journal of Breast Health metachronous cancer bilateral breast cancer |
| title | THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS |
| title_full | THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS |
| title_fullStr | THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS |
| title_full_unstemmed | THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS |
| title_short | THE EVALUATION OF METACHRONOUS BREAST CANCER PATIENTS |
| title_sort | evaluation of metachronous breast cancer patients |
| topic | metachronous cancer bilateral breast cancer |
| url |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/the-evaluaton-of-metachronous-breast-cancer-patent/42681
|
| work_keys_str_mv | AT onermentes theevaluationofmetachronousbreastcancerpatients AT muratakın theevaluationofmetachronousbreastcancerpatients AT erkanozturk theevaluationofmetachronousbreastcancerpatients AT mujdatbalkan theevaluationofmetachronousbreastcancerpatients AT turguttufan theevaluationofmetachronousbreastcancerpatients AT onermentes evaluationofmetachronousbreastcancerpatients AT muratakın evaluationofmetachronousbreastcancerpatients AT erkanozturk evaluationofmetachronousbreastcancerpatients AT mujdatbalkan evaluationofmetachronousbreastcancerpatients AT turguttufan evaluationofmetachronousbreastcancerpatients |